Finance

Lists
ABL:ETR
Abbott Laboratories
94,78 €
-1,56%
(-1,50) 1D
18 қар., 10:11:09 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ABL...
Open
95,44 €
High
95,80 €
Low
94,78 €
Mkt. cap
181,35 млрд
Avg. vol.
808,00
Volume
159,00
52-wk high
112,40 €
52-wk low
70,10 €
No. of employees
115 м.
Open
95,44 €
High
95,80 €
Low
94,78 €
Mkt. cap
181,35 млрд
Avg. vol.
808,00
Volume
159,00
52-wk high
112,40 €
52-wk low
70,10 €
No. of employees
115 м.
News stories
From web sources and news partners
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115 м.
Founded1888
HeadquartersЧикаго, Иллинойс, Америка Құрама Штаттары
SectorHealth Care
IndustryMedical device
Websiteabbott.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
11,46 млрд
11,16 млрд
12,59 млрд
13,01 млрд
Cost of goods sold
4,91 млрд
4,89 млрд
5,32 млрд
5,63 млрд
Cost of revenue
4,91 млрд
4,89 млрд
5,32 млрд
5,63 млрд
Research and development expenses
720,00 млн
767,00 млн
892,00 млн
920,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,93 млрд
3,58 млрд
3,87 млрд
4,11 млрд
Operating expense
4,07 млрд
4,77 млрд
5,42 млрд
5,87 млрд
Total operating expenses
8,98 млрд
9,66 млрд
10,74 млрд
11,50 млрд
Operating income
2,48 млрд
1,50 млрд
1,85 млрд
1,52 млрд
Other non operating income
-15,00 млн
-
-25,00 млн
5,00 млн
EBT including unusual items
2,36 млрд
1,45 млрд
1,52 млрд
1,23 млрд
EBT excluding unusual items
2,44 млрд
1,45 млрд
1,52 млрд
1,23 млрд
Income tax expense
582,00 млн
372,00 млн
596,00 млн
311,00 млн
Effective tax rate
24,68%
25,67%
39,11%
25,26%
Other operating expenses
-
-
-
-
Net income
1,78 млрд
1,08 млрд
928,00 млн
920,00 млн
Net profit margin
15,50%
9,65%
7,37%
7,07%
Earnings per share
1,50
1,15
1,31
1,42
Interest and investment income
78,00 млн
106,00 млн
52,00 млн
53,00 млн
Interest expense
-120,00 млн
-174,00 млн
-351,00 млн
-350,00 млн
Net interest expenses
-42,00 млн
-68,00 млн
-299,00 млн
-297,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
3,27 млрд
2,31 млрд
2,91 млрд
2,77 млрд
Gain or loss from assets sale
65,00 млн
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары